Hemostatic agents help to stop bleeding from the blood vessels. Also known as hemostasis, it works by contracting tissues to cure bleeding cuts. It cures the wounds by different mechanisms like concentration of coagulating factors, adhesion of tissues that are bleeding, and delivery of procoagulent factors to the cut location. Currently, these hemostasis are substantially advanced in terms of efficiency and overcoming the previous drawbacks. According to the growing quick approvals from the FDA, hemostatic agents have been developed speedily and are also practically used in widely including battlefield, apart from simply healthcare. They carry huge impotence in cases where heavy bleeding might also result in death.
Market Industry Reports (MIR) has published a new report titled "Global Hemostatic Agents Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global hemostatic agents market was estimated to be over US$ 3 Bn in 2018. It is anticipated to grow at a CAGR of 6.1% from 2019 to 2030.Major Key Players of the Hemostatic Agents Market are:
Baxter, Ethicon US, C. R. Bard, B. Braun Melsungen AG, Pfizer, Z-Medica, CryoLife, Integra LifeSciences, Advanced Medical Solutions Group plc. GELITA AG.
No comments:
Post a Comment